Limosilactobacillus fermentum
Limosilactobacillus fermentum is a species of bacteria that belongs to the genus Limosilactobacillus. It is a Gram-positive, facultative anaerobic, rod-shaped bacterium. L. fermentum is commonly found in fermented foods and in the gastrointestinal tract of humans and animals.
Taxonomy[edit]
Limosilactobacillus fermentum was first described in 1928 by Ferdinand Adalbert Krienitz. The species was originally classified under the genus Lactobacillus, but was reclassified to the newly established genus Limosilactobacillus in 2020 following a major revision of the Lactobacillus genus based on phylogenetics and metagenomics.
Characteristics[edit]
L. fermentum is a heterofermentative bacterium, meaning it can ferment sugars into a mixture of products, including lactic acid, ethanol, and carbon dioxide. It is capable of surviving in a wide range of environmental conditions, including varying temperatures and pH levels.
Role in Fermentation[edit]
L. fermentum plays a significant role in the fermentation of many foods and beverages, including yogurt, cheese, wine, and beer. It contributes to the taste, texture, and nutritional value of these products.
Health Benefits[edit]
L. fermentum is considered a probiotic due to its potential health benefits. It has been studied for its effects on gastrointestinal health, immune system function, and cholesterol levels. Some strains of L. fermentum have also been found to have antimicrobial properties.
Safety[edit]
While L. fermentum is generally considered safe for consumption, some strains may cause infections in immunocompromised individuals. As with all probiotics, it is recommended to consult a healthcare provider before starting a new supplement regimen.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian